Proteome Sciences (LON:PRM) Shares Down 9.8% – Here’s What Happened
by Mitch Edgeman · The Markets DailyProteome Sciences plc (LON:PRM – Get Free Report) fell 9.8% during trading on Wednesday . The stock traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). 41,420 shares traded hands during mid-day trading, a decline of 55% from the average session volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).
Proteome Sciences Trading Up 40.4 %
The company has a 50 day moving average price of GBX 2.92 and a 200 day moving average price of GBX 3.11. The company has a market capitalization of £14.17 million, a price-to-earnings ratio of -480.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year